EUVIMEDEUVIMED entdecken
Crossref

Nephrotoxicity associated with short-term gentamicin therapy in community-acquired bacteraemia: risk of nephrotoxicity

Oliver Wagner Ulf Nielsen, Mikkel Oliver Skov Risom, Hans Linde Nielsen, Jacob Bodilsen, Henrik Nielsen

Danish Medical Journal · 2025

DOI: 10.61409/a08240568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Danish Medical Journal, 2025. Verfasst von Oliver Wagner Ulf Nielsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Aalborg University Hospital. Hauptthemen laut MEDLINE: Gentamicins, Bacteremia, Acute Kidney Injury, Anti-Bacterial Agents. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION. Hesitancy towards the use of aminoglycosides persists among clinicians due to the perceived risk of nephrotoxicity. METHODS. This retrospective cohort study included adults with community-acquired bacteraemia and no pre-existing renal failure. The patients were divided into two groups matched 1:1 by age (± 5 years): 1) patients treated with short-term (≤ 3 days) once-daily gentamicin within 24 hours of admission and 2) non-gentamicin-treated patients. The primary endpoint was an increase in plasma creatinine levels of ≥ 40 µmol/l from baseline. Cause-specific Cox regression was used to compute hazard ratios (HR) with 95% confidence intervals (CI) for prognostic factors of acute kidney injury (AKI) and death. RESULTS. A total of 310 adults with bacteraemia were included, among whom 159 (49%) were treated with gentamicin and 151 (51%) with other antibiotics. No significant between-group differences were observed in sex distribution, comorbidities, biochemical variables and vital signs at admission. In the gentamicin-exposed group, 11 (7%) patients developed AKI compared with 12 (8%) patients in the non-exposed group. Gentamicin was neither associated with increased risk of AKI (HR = 0.86; 95% CI: 0.38-1.96) nor with 30-day mortality (HR = 0.73; 95% CI: 0.38-1.41) compared with other antibiotic regimens. CONCLUSIONS. Our study showed no increase in the risk of developing AKI and no increase in all-cause mortality in patients treated with short-term once-daily gentamicin for community-acquired bacteraemia compared with other antibiotic regimens. FUNDING. None. TRIAL REGISTRATION. Not relevant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GentamicinsBacteremiaAcute Kidney InjuryAnti-Bacterial AgentsHumansMaleFemaleRetrospective StudiesCommunity-Acquired InfectionsMiddle AgedAgedCreatinineProportional Hazards ModelsRisk FactorsAdultAged, 80 and over

Substanzen

GentamicinsAnti-Bacterial AgentsCreatinine

Autor:innen und Institutionen

  • Department of Infectious Diseases, Aalborg University Hospital.
  • Department of Clinical Microbiology, Aalborg University Hospital.
  • Department of Clinical Medicine, Aalborg University, Denmark.

Zitieren

APA

Nielsen, O. W. U., Risom, M. O. S., Nielsen, H. L., Bodilsen, J., & Nielsen, H. (2025). Nephrotoxicity associated with short-term gentamicin therapy in community-acquired bacteraemia: risk of nephrotoxicity. Danish Medical Journal. https://doi.org/10.61409/a08240568

Vancouver

Nielsen OWU, Risom MOS, Nielsen HL, Bodilsen J, Nielsen H. Nephrotoxicity associated with short-term gentamicin therapy in community-acquired bacteraemia: risk of nephrotoxicity. Danish Medical Journal. 2025. doi:10.61409/a08240568

BibTeX
@article{Nielsen2025,
  author = {Nielsen, Oliver Wagner Ulf and Risom, Mikkel Oliver Skov and Nielsen, Hans Linde and Bodilsen, Jacob and Nielsen, Henrik},
  title = {Nephrotoxicity associated with short-term gentamicin therapy in community-acquired bacteraemia: risk of nephrotoxicity},
  journal = {Danish Medical Journal},
  year = {2025},
  doi = {10.61409/a08240568}
}
Kostenlos starten →